TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+10.56%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.98B
AUM Growth
+$171M
(+9.4%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
220
New
18
Increased
34
Reduced
52
Closed
20
Top Buys
| 1 |
Vera Therapeutics
VERA
|
$28.3M |
| 2 |
Merus
MRUS
|
$26.3M |
| 3 |
Mettler-Toledo International
MTD
|
$22.9M |
| 4 |
Boeing
BA
|
$20.9M |
| 5 |
Spyre Therapeutics
SYRE
|
$17.2M |
Top Sells
| 1 |
Dynavax Technologies
DVAX
|
$37.7M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$29M |
| 3 |
SLRN
ACELYRIN
SLRN
|
$24.3M |
| 4 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.1M |
| 5 |
CRISPR Therapeutics
CRSP
|
$9.07M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Technology | 1.37% |
| 3 | Industrials | 1.32% |
| 4 | Communication Services | 1.26% |
| 5 | Consumer Discretionary | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ionis Pharmaceuticals
IONS
$9.46B
| $5.93M | 0.3% |
150,000
| – | – |
|
77
Stoke Therapeutics
STOK
$1.08B
| $5.68M | 0.29% |
500,000
| – | – |
|
78
Edgewise Therapeutics
EWTX
$1.54B
| $5.65M | 0.29% |
431,300
+131,300
| +44% | +$1.72M |
|
79
Summit Therapeutics
SMMT
$17.7B
| $5.32M | 0.27% |
+250,000
| New | +$5.32M |
|
80
Regeneron Pharmaceuticals
REGN
$60.1B
| $5.25M | 0.27% |
10,000
| – | – |
|
81
Black Diamond Therapeutics
BDTX
$163M
| $5.13M | 0.26% |
2,070,209
| – | – |
|
|
THRD
82
DELISTED
Third Harmonic Bio
THRD
| $5.05M | 0.26% |
929,727
| – | – |
|
83
Adicet Bio
ACET
$59.4M
| $5.02M | 0.25% |
8,223,612
| – | – |
|
84
Dianthus Therapeutics
DNTH
$794M
| $4.93M | 0.25% |
264,692
| – | – |
|
85
Bausch Health
BHC
$2.67B
| $4.91M | 0.25% |
+736,827
| New | +$4.91M |
|
86
Janux Therapeutics
JANX
$1.44B
| $4.62M | 0.23% |
200,000
+50,000
| +33% | +$1.16M |
|
87
Vertex Pharmaceuticals
VRTX
$102B
| $4.45M | 0.23% |
+10,000
| New | +$4.45M |
|
88
Heron Therapeutics
HRTX
$202M
| $4.42M | 0.22% |
2,135,459
-100,000
| -4% | -$207K |
|
89
Biogen
BIIB
$20.5B
| $4.4M | 0.22% |
35,000
| – | – |
|
90
Soleno Therapeutics
SLNO
$3.7B
| $4.19M | 0.21% |
50,000
| – | – |
|
91
Genmab
GMAB
$16.8B
| $4.13M | 0.21% |
200,000
| – | – |
|
92
Lantheus
LNTH
$3.66B
| $4.09M | 0.21% |
50,000
| – | – |
|
93
MindMed
MNMD
$702M
| $3.9M | 0.2% |
600,200
+200,000
| +50% | +$1.3M |
|
94
Nuvalent
NUVL
$5.74B
| $3.82M | 0.19% |
50,000
| – | – |
|
95
Novavax
NVAX
$1.27B
| $3.78M | 0.19% |
600,000
| – | – |
|
96
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $3.73M | 0.19% |
5,097,362
| – | – |
|
97
Revolution Medicines
RVMD
$7.28B
| $3.68M | 0.19% |
100,000
| – | – |
|
|
CMPS
98
Compass Pathways
CMPS
$489M
| $3.64M | 0.18% |
1,300,000
-100,000
| -7% | -$280K |
|
99
TG Therapeutics
TGTX
$5.06B
| $3.6M | 0.18% |
100,000
| – | – |
|
|
TECX
100
Tectonic Therapeutic, Inc. Common Stock
TECX
$323M
| $3.56M | 0.18% |
179,166
| – | – |
|